Physician profile
Dan Li
NPI 1164804266
$16,478.25
in general payments reported to CMS, 2019-2025
15 companies · $7,611 in 2025
The $7,611 reported for 2025 was more than what 75% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $396 · 2022: $2,281 · 2023: $843 · 2024: $5,348 · 2025: $7,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,402 · Travel and Lodging: $6,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,401.66 |
| Travel and Lodging | $6,399.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,445.61 | 2023-2025 | Ensite, Aveir, Ensite Precision |
| Boston Scientific Corporation | $1,992.90 | 2024-2025 | Farapulse, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $1,944.89 | 2024-2025 | Evera Mri Xt Dr Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| Medical Device Business Services, INC. | $1,638.53 | 2024 | Carto 3 |
| Biotronik INC. | $452.49 | 2023-2025 | Acticor 7 Vr-T Dx, Plexa Promri, Pamira |
| Biosense Webster, INC. | $373.91 | 2023-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $315.53 | 2023-2025 | Lifevest |
| Atricure, INC. | $180.55 | 2025 | Atriclip Laa Exclusion System |
| Abiomed | $148.13 | 2024 | Impella |
| Heartflow, INC. | $145.86 | 2025 | |
| Itamar Medical INC | $97.28 | 2023-2025 | Watchpatone |
| Cvrx, INC. | $26.84 | 2024 | Barostim Neo System |
| Novo Nordisk INC | $22.29 | 2025 | Ozempic |
| Recor Medical INC | $16.52 | 2024 | Paradise Renal Denervation System |
| Astrazeneca Pharmaceuticals LP | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.